We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Safety Blood Collection Device Eliminates Needlestick Risk

By LabMedica International staff writers
Posted on 05 May 2011
A new blood collection device is completely passive, automatically hiding the needle without the clinician having to perform any additional tasks.

The Vacuette Premium Tube-Touch safety-needle system blood collection device is designed with an integrated, multiple sample needle and safety shield safety mechanism that automatically activates through normal use, with no additional step by the user. More...
Insertion of the first blood collection tube causes the safety shield to be automatically released, which automatically covers the needle immediately following blood collection from the patient. The Tube-Touch is available in 20G, 21G, and 22G gauges.

Vacuette tube-activated blood collection devices employ a mode of action that impinges on the safety trigger, causing wing-like sheaths to deploy around the needle. Blood cannot be drawn unless the safety system has been engaged. If the vein is missed, the phlebotomist can reposition with the same device, provided a collection tube has not been inserted into the collection device. The Vacuette Premium Tube-Touch is a product of Greiner Bio-One (Kremsmünster, Austria), and has been approved by the US Food and Drug Administration (FDA).

"Greiner Bio-One introduced the first plastic evacuated blood collection tube on the market to provide phlebotomist, nurse, and laboratory professionals a new level of safety and product effectiveness that would help to eliminate the use of dangerous glass tubes,” said Franz Konrad, CEO of Greiner Bio-One. "We continue to provide a high level of service to the medical professional community in the products we bring to customers.”

Healthcare workers worldwide experience millions of needlestick injuries per year, and as many as two-thirds of these events go unreported; US hospitals report approximately 30 needlestick injuries per year for every 100 beds. Needlesticks have been responsible for infections from more than 20 different infectious agents, including human immunodeficiency virus (HIV), Hepatitis B virus (HBV), and Hepatitis C virus (HCV). The rate of infection following needlestick exposure has been calculated for HIV as 0.3%; figures for HCV and HBV have been reported as 1.7% and as high as 30%, respectively. While most needlestick injuries carry no adverse health consequences, the possibility of infection with life-threatening microbes exists, especially with exposure to body fluids.

Related Links:

Greiner Bio-One



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Biodesix is developing a radiomics-based lung nodule risk assessment test to complement its Nodify Lung portfolio (Photo courtesy of Biodesix)

Multimodal Platform to Combine Blood and Imaging Biomarkers for Lung Nodule Assessment

Lung nodules are commonly detected during chest imaging and require careful risk assessment to determine whether follow-up imaging, additional testing, or biopsy is needed. With millions of patients evaluated... Read more

Molecular Diagnostics

view channel
Image

GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

GeneDx (Gaithersburg, MD, USA) is presenting 27 scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting, taking place October 20–24 in Montreal, Canada.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.